Multiple sclerosis associated fatigue during natalizumab treatment
- 15 October 2009
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 285 (1-2), 109-113
- https://doi.org/10.1016/j.jns.2009.06.004
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prevalence and Severity of Multiple-Sclerosis-Associated Fatigue in Treated and Untreated PatientsEuropean Neurology, 2007
- Health‐related quality of life in multiple sclerosis: effects of natalizumabAnnals of Neurology, 2007
- Coping and quality of life in one hundred and thirty five subjects with multiple sclerosisMultiple Sclerosis Journal, 2007
- Costs and quality of life of patients with multiple sclerosis in EuropeJournal of Neurology, Neurosurgery & Psychiatry, 2006
- A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple SclerosisThe New England Journal of Medicine, 2006
- Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?Journal of Neurology, Neurosurgery & Psychiatry, 2006
- The effect of immunomodulatory treatment on multiple sclerosis fatigueJournal of Neurology, Neurosurgery & Psychiatry, 2004
- Functional Magnetic Resonance Imaging Correlates of Fatigue in Multiple SclerosisNeuroImage, 2002
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Fatigue in MS is associated with specific clinical featuresActa Neurologica Scandinavica, 1995